Financials Qatari German Company for Medical Devices (Q.P.S.C.)
Equities
QGMD
QA0001200763
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 QAR | +1.41% | -0.07% | -5.58% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 65.37 | 67.22 | 258.4 | 367.3 | 145.2 | 167.6 |
Enterprise Value (EV) 1 | 182.6 | 186.3 | 396.9 | 504.2 | 283.8 | 309.8 |
P/E ratio | -5.09 x | -6.47 x | 292 x | 311 x | 117 x | 125 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.73 x | 8.25 x | 10.5 x | 9.06 x | 3.4 x | 6.02 x |
EV / Revenue | 16 x | 22.9 x | 16.2 x | 12.4 x | 6.65 x | 11.1 x |
EV / EBITDA | -57.8 x | -147 x | 81.9 x | 44.4 x | 27 x | 73.1 x |
EV / FCF | -209 x | 80.4 x | -22 x | 444 x | -144 x | -60.5 x |
FCF Yield | -0.48% | 1.24% | -4.55% | 0.23% | -0.69% | -1.65% |
Price to Book | 1.59 x | 2.19 x | 8.2 x | 11.2 x | 4.21 x | 4.65 x |
Nbr of stocks (in thousands) | 115,500 | 115,500 | 115,500 | 115,500 | 115,500 | 115,500 |
Reference price 2 | 0.5660 | 0.5820 | 2.237 | 3.180 | 1.257 | 1.451 |
Announcement Date | 3/28/19 | 3/30/20 | 3/4/21 | 3/16/22 | 3/16/23 | 2/8/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 11.4 | 8.144 | 24.57 | 40.55 | 42.66 | 27.85 |
EBITDA 1 | -3.158 | -1.266 | 4.848 | 11.37 | 10.49 | 4.239 |
EBIT 1 | -8.811 | -6.787 | -0.6271 | 5.962 | 5.071 | -1.106 |
Operating Margin | -77.27% | -83.33% | -2.55% | 14.7% | 11.89% | -3.97% |
Earnings before Tax (EBT) 1 | -12.83 | -10.39 | 0.8842 | 1.181 | 1.244 | 1.336 |
Net income 1 | -12.83 | -10.39 | 0.8842 | 1.181 | 1.244 | 1.336 |
Net margin | -112.55% | -127.53% | 3.6% | 2.91% | 2.92% | 4.8% |
EPS 2 | -0.1111 | -0.0899 | 0.007655 | 0.0102 | 0.0108 | 0.0116 |
Free Cash Flow 1 | -0.8736 | 2.316 | -18.04 | 1.135 | -1.966 | -5.121 |
FCF margin | -7.66% | 28.44% | -73.45% | 2.8% | -4.61% | -18.39% |
FCF Conversion (EBITDA) | - | - | - | 9.98% | - | - |
FCF Conversion (Net income) | - | - | - | 96.08% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/28/19 | 3/30/20 | 3/4/21 | 3/16/22 | 3/16/23 | 2/8/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 117 | 119 | 139 | 137 | 139 | 142 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -37.11 x | -94.08 x | 28.57 x | 12.05 x | 13.21 x | 33.56 x |
Free Cash Flow 1 | -0.87 | 2.32 | -18 | 1.13 | -1.97 | -5.12 |
ROE (net income / shareholders' equity) | -27% | -29% | 2.84% | 3.68% | 3.71% | 3.79% |
ROA (Net income/ Total Assets) | -3.3% | -2.68% | -0.23% | 2.03% | 1.66% | -0.35% |
Assets 1 | 388.4 | 387.5 | -377.5 | 58.31 | 74.91 | -381.9 |
Book Value Per Share 2 | 0.3600 | 0.2700 | 0.2700 | 0.2800 | 0.3000 | 0.3100 |
Cash Flow per Share 2 | 0 | 0.0100 | 0.0300 | 0.0400 | 0.0500 | 0 |
Capex 1 | 0.25 | 0.09 | 0.66 | 0.56 | 0.25 | 1.05 |
Capex / Sales | 2.18% | 1.05% | 2.71% | 1.38% | 0.59% | 3.78% |
Announcement Date | 3/28/19 | 3/30/20 | 3/4/21 | 3/16/22 | 3/16/23 | 2/8/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-5.58% | 43.47M | |
+10.85% | 27.84B | |
-29.83% | 3.04B | |
-14.68% | 2.56B | |
+11.64% | 2.33B | |
+2.96% | 1.99B | |
-11.65% | 1.87B | |
-1.67% | 1.49B | |
+2.19% | 1.27B | |
+3.72% | 1.12B |
- Stock Market
- Equities
- QGMD Stock
- Financials Qatari German Company for Medical Devices (Q.P.S.C.)